MKL
MKL
Markel CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $3.55B ▼ | $2.66B ▲ | $-212.29M ▼ | -5.98% ▼ | $-18.9 ▼ | $-229.82M ▼ |
| Q4-2025 | $4.22B ▼ | $2.2B ▲ | $576.81M ▼ | 13.67% ▼ | $48.95 ▼ | $784.17M ▼ |
| Q3-2025 | $4.39B ▼ | $1.43B ▼ | $751.34M ▲ | 17.13% ▲ | $59.44 ▲ | $1.07B ▲ |
| Q2-2025 | $4.41B ▲ | $1.59B ▲ | $657.15M ▲ | 14.9% ▲ | $49.8 ▲ | $966.64M ▲ |
| Q1-2025 | $3.33B | $1.35B | $121.71M | 3.66% | $12.11 | $256.83M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $10.86B ▼ | $68.6B ▼ | $49.95B ▲ | $18.13B ▼ |
| Q4-2025 | $11.03B ▲ | $68.91B ▲ | $49.8B ▲ | $18.6B ▲ |
| Q3-2025 | $4.62B ▲ | $50.7B ▲ | $32.1B ▲ | $18.04B ▲ |
| Q2-2025 | $4.3B ▼ | $49.44B ▲ | $31.57B ▲ | $17.32B ▲ |
| Q1-2025 | $4.67B | $48.65B | $30.9B | $17.15B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-204.36M ▼ | $15.91M ▼ | $-348.22M ▲ | $-79.55M ▼ | $-422.02M ▼ | $-31.35M ▼ |
| Q4-2025 | $576.81M ▼ | $662.19M ▼ | $-615.44M ▲ | $-50.05M ▲ | $-13.6M ▼ | $599.07M ▼ |
| Q3-2025 | $763.79M ▲ | $1.22B ▲ | $-719.3M ▼ | $-170.83M ▲ | $321.81M ▲ | $1.17B ▲ |
| Q2-2025 | $677.18M ▲ | $504.4M ▲ | $-109.41M ▼ | $-821.95M ▼ | $-379.85M ▼ | $453.76M ▲ |
| Q1-2025 | $129.35M | $376.19M | $192.81M | $-105.8M | $482.69M | $335.48M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Insurance | $1.86Bn ▲ | $1.86Bn ▲ | $1.82Bn ▼ | $0 ▼ |
Investing Member | $1.17Bn ▲ | $370.00M ▼ | $80.00M ▼ | $0 ▼ |
Markel Ventures | $0 ▲ | $0 ▲ | $0 ▲ | $1.55Bn ▲ |
Markel Ventures Operations | $1.26Bn ▲ | $1.27Bn ▲ | $1.13Bn ▼ | $0 ▼ |
Reinsurance | $250.00M ▲ | $260.00M ▲ | $270.00M ▲ | $0 ▼ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Markel Corporation's financial evolution and strategic trajectory over the past five years.
Key strengths include a distinctive three‑engine business model, strong recovery and growth in profitability, and consistently robust free cash flow. The balance sheet has expanded with rising equity and retained earnings, while leverage remains moderate. Markel’s specialty focus, underwriting discipline, and long‑term investment orientation, combined with its portfolio of operating businesses, provide diversification that many traditional insurers lack. Its measured embrace of technology and insurtech partnerships further supports underwriting quality and operational efficiency.
Main risks center on the inherent volatility of insurance and investment results, as seen in past loss years and revenue swings. The recent revenue contraction after a period of strong growth raises questions about market conditions and competitive dynamics. Catastrophe events, liability inflation, regulatory changes, and pricing cycles can all pressure underwriting profitability. On the financial side, the shift from net cash to net debt, increased shareholder distributions, and opacity around some liquidity metrics modestly raise financial risk, while acquisitions within Markel Ventures carry integration and execution risk.
Overall, the data depict a company that has emerged from a difficult period with stronger profitability, a larger capital base, and multiple engines of cash generation. Its long‑term prospects depend on maintaining underwriting discipline, navigating insurance cycles, compounding investment returns prudently, and continuing to build Markel Ventures without sacrificing quality. Results are likely to remain lumpy year to year due to the nature of the business, but the structural setup and recent trends suggest it is well placed to continue pursuing long‑term value creation if current strategies are sustained and risks are managed carefully.
About Markel Corporation
https://www.markel.comMarkel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, Bermuda, the United Kingdom, rest of Europe, Canada, the Asia Pacific, and the Middle East.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $3.55B ▼ | $2.66B ▲ | $-212.29M ▼ | -5.98% ▼ | $-18.9 ▼ | $-229.82M ▼ |
| Q4-2025 | $4.22B ▼ | $2.2B ▲ | $576.81M ▼ | 13.67% ▼ | $48.95 ▼ | $784.17M ▼ |
| Q3-2025 | $4.39B ▼ | $1.43B ▼ | $751.34M ▲ | 17.13% ▲ | $59.44 ▲ | $1.07B ▲ |
| Q2-2025 | $4.41B ▲ | $1.59B ▲ | $657.15M ▲ | 14.9% ▲ | $49.8 ▲ | $966.64M ▲ |
| Q1-2025 | $3.33B | $1.35B | $121.71M | 3.66% | $12.11 | $256.83M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $10.86B ▼ | $68.6B ▼ | $49.95B ▲ | $18.13B ▼ |
| Q4-2025 | $11.03B ▲ | $68.91B ▲ | $49.8B ▲ | $18.6B ▲ |
| Q3-2025 | $4.62B ▲ | $50.7B ▲ | $32.1B ▲ | $18.04B ▲ |
| Q2-2025 | $4.3B ▼ | $49.44B ▲ | $31.57B ▲ | $17.32B ▲ |
| Q1-2025 | $4.67B | $48.65B | $30.9B | $17.15B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-204.36M ▼ | $15.91M ▼ | $-348.22M ▲ | $-79.55M ▼ | $-422.02M ▼ | $-31.35M ▼ |
| Q4-2025 | $576.81M ▼ | $662.19M ▼ | $-615.44M ▲ | $-50.05M ▲ | $-13.6M ▼ | $599.07M ▼ |
| Q3-2025 | $763.79M ▲ | $1.22B ▲ | $-719.3M ▼ | $-170.83M ▲ | $321.81M ▲ | $1.17B ▲ |
| Q2-2025 | $677.18M ▲ | $504.4M ▲ | $-109.41M ▼ | $-821.95M ▼ | $-379.85M ▼ | $453.76M ▲ |
| Q1-2025 | $129.35M | $376.19M | $192.81M | $-105.8M | $482.69M | $335.48M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Insurance | $1.86Bn ▲ | $1.86Bn ▲ | $1.82Bn ▼ | $0 ▼ |
Investing Member | $1.17Bn ▲ | $370.00M ▼ | $80.00M ▼ | $0 ▼ |
Markel Ventures | $0 ▲ | $0 ▲ | $0 ▲ | $1.55Bn ▲ |
Markel Ventures Operations | $1.26Bn ▲ | $1.27Bn ▲ | $1.13Bn ▼ | $0 ▼ |
Reinsurance | $250.00M ▲ | $260.00M ▲ | $270.00M ▲ | $0 ▼ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Markel Corporation's financial evolution and strategic trajectory over the past five years.
Key strengths include a distinctive three‑engine business model, strong recovery and growth in profitability, and consistently robust free cash flow. The balance sheet has expanded with rising equity and retained earnings, while leverage remains moderate. Markel’s specialty focus, underwriting discipline, and long‑term investment orientation, combined with its portfolio of operating businesses, provide diversification that many traditional insurers lack. Its measured embrace of technology and insurtech partnerships further supports underwriting quality and operational efficiency.
Main risks center on the inherent volatility of insurance and investment results, as seen in past loss years and revenue swings. The recent revenue contraction after a period of strong growth raises questions about market conditions and competitive dynamics. Catastrophe events, liability inflation, regulatory changes, and pricing cycles can all pressure underwriting profitability. On the financial side, the shift from net cash to net debt, increased shareholder distributions, and opacity around some liquidity metrics modestly raise financial risk, while acquisitions within Markel Ventures carry integration and execution risk.
Overall, the data depict a company that has emerged from a difficult period with stronger profitability, a larger capital base, and multiple engines of cash generation. Its long‑term prospects depend on maintaining underwriting discipline, navigating insurance cycles, compounding investment returns prudently, and continuing to build Markel Ventures without sacrificing quality. Results are likely to remain lumpy year to year due to the nature of the business, but the structural setup and recent trends suggest it is well placed to continue pursuing long‑term value creation if current strategies are sustained and risks are managed carefully.

CEO
Thomas Sinnickson Gayner
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1989-09-11 | Forward | 6:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 473
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
CANERECTOR INC
Shares:10.7M
Value:$19.43B
VANGUARD GROUP INC
Shares:1.17M
Value:$2.13B
BLACKROCK INC.
Shares:750.01K
Value:$1.36B
Summary
Showing Top 3 of 1,236

